PATEL DINESH V PH D — SEC insider filings

SEC reporting owner CIK 1120477. 44 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 44 filings on record, filed 2021-01-20 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Protagonist Therapeutics, Inc (PTGX)President and CEO, Director44—27 legs · 885,475 sh · $74,401,46578

Insider filings — PATEL DINESH V PH D

FiledFormIssuerReported transactionsSource
2026-11-204Protagonist Therapeutics, Inc (PTGX)Gift (G): 300 @ $0EDGAR
2026-09-104Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 54,174 @ $21.58 · Sale (S): 54,174 @ $145.87 · Option exercise (M): 63,548 @ $21.58 · Sale (S): 63,548 @ $146.18 · Option exercise (M): 7,278 @ $21.58 · Sale (S): 7,278 @ $144.10 · +3 moreEDGAR
2026-09-084Protagonist Therapeutics, Inc (PTGX)Gift (G): 510 @ $0EDGAR
2026-08-124Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 65,761 @ $21.58 · Sale (S): 65,761 @ $149.11 · Option exercise (M): 34,239 @ $21.58 · Sale (S): 34,239 @ $148.52 · Option exercise (M): 65,761 (derivative) @ $0 · Option exercise (M): 34,239 (derivative) @ $0EDGAR
2026-05-144/AProtagonist Therapeutics, Inc (PTGX)Option exercise (M): 75,000 @ $21.58 · Sale (S): 75,000 @ $100.12 · Option exercise (M): 75,000 (derivative) @ $0EDGAR
2026-05-124Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 75,000 @ $21.58 · Sale (S): 75,000 @ $100.12 · Option exercise (M): 75,000 (derivative) @ $0EDGAR
2026-04-244Protagonist Therapeutics, Inc (PTGX)Gift (G): 1,460 @ $0EDGAR
2026-03-254Protagonist Therapeutics, Inc (PTGX)Gift (G): 50,000 @ $0 · Option exercise (M): 59 @ $8.58 · Sale (S): 59 @ $101 · Option exercise (M): 54,641 @ $8.58 · Sale (S): 54,641 @ $101 · Option exercise (M): 59 (derivative) @ $0 · +1 moreEDGAR
2026-01-274Protagonist Therapeutics, Inc (PTGX)Gift (G): 6,000 @ $0 · Option exercise (M): 19,315 @ $4.21 · Sale (S): 19,315 @ $84.59 · Option exercise (M): 10,685 @ $4.21 · Sale (S): 10,685 @ $84 · Option exercise (M): 14,205 @ $21.58 · +7 moreEDGAR
2026-01-214Protagonist Therapeutics, Inc (PTGX)Sale (S): 34,438 @ $82.48EDGAR
2026-01-064Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 95,400 @ $0 · Grant/award (A): 120,200 (derivative) @ $0EDGAR
2025-11-244Protagonist Therapeutics, Inc (PTGX)Gift (G): 440 @ $0EDGAR
2025-09-184Protagonist Therapeutics, Inc (PTGX)Gift (G): 620 @ $0EDGAR
2025-07-284Protagonist Therapeutics, Inc (PTGX)Sale (S): 10,415 @ $54.78EDGAR
2025-07-234Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 25,000 @ $0 · Sale (S): 12,859 @ $54.86 · Sale (S): 22,065 @ $55.05 · Sale (S): 17,520 @ $54.79EDGAR
2025-07-184Protagonist Therapeutics, Inc (PTGX)Gift (G): 5,000 @ $0EDGAR
2025-06-174Protagonist Therapeutics, Inc (PTGX)Gift (G): 670 @ $0 · Gift (G): 685 @ $0EDGAR
2025-03-054Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 24,000 @ $4.21 · Option exercise (M): 24,000 (derivative) @ $0EDGAR
2025-02-204Protagonist Therapeutics, Inc (PTGX)Sale (S): 5,359 @ $38.18EDGAR
2025-01-174Protagonist Therapeutics, Inc (PTGX)Tax withholding (F): 12,636 @ $0EDGAR
2025-01-064Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 149,800 @ $0 · Grant/award (A): 181,472 (derivative) @ $0EDGAR
2024-11-274Protagonist Therapeutics, Inc (PTGX)Sale (S): 78,520 @ $46.96 · Gift (G): 7,000 @ $0 · Option exercise (M): 1,727 @ $21.58 · Sale (S): 21,480 @ $46.25 · Option exercise (M): 1,727 (derivative) @ $0EDGAR
2024-11-214Protagonist Therapeutics, Inc (PTGX)Gift (G): 1,000 @ $0EDGAR
2024-06-174Protagonist Therapeutics, Inc (PTGX)Gift (G): 1,000 @ $0EDGAR
2024-06-114Protagonist Therapeutics, Inc (PTGX)Sale (S): 35,000 @ $35.19EDGAR
2024-04-024Protagonist Therapeutics, Inc (PTGX)Sale (S): 25,000 @ $28.31EDGAR
2024-03-014Protagonist Therapeutics, Inc (PTGX)Sale (S): 30,000 @ $31.62EDGAR
2024-02-284Protagonist Therapeutics, Inc (PTGX)Tax withholding (F): 10,915 @ $29.53EDGAR
2024-02-204Protagonist Therapeutics, Inc (PTGX)Tax withholding (F): 3,717 @ $28.23EDGAR
2024-01-044Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 84,875 @ $0 · Grant/award (A): 315,250 (derivative) @ $0EDGAR
2023-12-154Protagonist Therapeutics, Inc (PTGX)Sale (S): 75,000 @ $20.08EDGAR
2023-10-194Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 6,000 @ $4.21 · Option exercise (M): 6,000 (derivative) @ $0EDGAR
2023-06-024Protagonist Therapeutics, Inc (PTGX)Gift (G): 10,000 @ $0 · Grant/award (A): 30,000 @ $0 · Tax withholding (F): 12,165 @ $26.07EDGAR
2023-01-184Protagonist Therapeutics, Inc (PTGX)Gift (G): 3,000 @ $0 · Gift (G): 3,116 @ $0 · Grant/award (A): 600,000 (derivative) @ $0EDGAR
2022-08-244Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 20,000 @ $4.21 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2022-05-044Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 15,742 @ $4.21 · Option exercise (M): 15,742 (derivative) @ $0EDGAR
2022-04-264Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 30,000 @ $4.21 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2022-04-144Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 34,087 @ $1.89 · Option exercise (M): 34,087 (derivative) @ $0EDGAR
2022-03-024Protagonist Therapeutics, Inc (PTGX)Tax withholding (F): 4,648 @ $24.28EDGAR
2022-02-174Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 31,250 @ $0 · Grant/award (A): 187,500 (derivative) @ $0EDGAR
2021-12-234Protagonist Therapeutics, Inc (PTGX)Sale (S): 15,000 @ $32.14EDGAR
2021-09-214Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 40,000 @ $4.21 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2021-02-264Protagonist Therapeutics, Inc (PTGX)Grant/award (A): 25,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0EDGAR
2021-01-204Protagonist Therapeutics, Inc (PTGX)Option exercise (M): 13,000 @ $4.21 · Sale (S): 24,846 @ $24.60 · Option exercise (M): 13,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1120477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs